Novo Nordisk has repurchased 17,275,000 B shares under its share repurchase programme initiated on 6 May 2026, part of an overall programme of up to DKK 15 billion running from 4 February 2026. The latest transactions, announced on 7 September 2026, cover purchases made between 31 August and 4 September, bringing the total transaction value under the May programme to DKK 5,221,774,293. Since 4 February, the company has repurchased 32,034,179 B shares at an average price of DKK 281.63 per share, for a total of DKK 9,021,774,283. Novo Nordisk now holds 46,074,876 B shares as treasury shares, representing 1.0% of its share capital.
Novo Nordisk A/SNovo Nordisk is actively repurchasing its own shares under a DKK 15 billion buyback programme, which typically supports share price.
